11 articles found
Among 110,136 veterans with opioid use disorder, White patients' medication rates rose to 35% by 2022 while Black patients reached 29.3%, a new VA study finds.
Montgomery County commissioners approved $98,661 in 2027 opioid settlement mini-grants for 13 local organizations, from peer recovery coaches to a veterans treatment court.
Fargo's Veterans Treatment Court held its grand opening Oct. 9 at the Cass County Courthouse, joining Grand Forks and a new veterans court in Oneida County, New York.
The FDA is taking public comment through Nov. 20 on how the first federally funded ibogaine trials should handle dosing, cardiac monitoring and safety.
The VA awarded $111.9 million through the Staff Sergeant Parker Gordon Fox program to 191 community organizations serving veterans, the largest round of the grant's history.
The VA will require signed consent before combined opioid and benzodiazepine prescriptions and before antidepressants for veterans under 30, starting in 2027.
Governor Newsom signed AB 113, allocating $4.7 million for California's first state-funded research into psychedelic therapy for veterans with treatment-resistant PTSD.
The VA's CRAVE trial will enroll more than 600 veterans at 18 medical centers to test whether weekly semaglutide injections can treat alcohol use disorder.
Texas begins first state-funded Phase 1 clinical trials of ibogaine for opioid use disorder, PTSD, and traumatic brain injuries with additional legislative funding.
The Department of Veterans Affairs is expanding FDA-authorized virtual reality therapy to treat chronic pain in veterans, offering an eight-week home-based program that reduces reliance on opioids.
New Hope Valley facility offers residential detox, trauma therapy, and holistic wellness for Alaska's veterans and active-duty members in a state with the highest per-capita veteran population.